BioCentury
ARTICLE | Company News

Roche, Astellas deal

May 25, 2015 7:00 AM UTC

Roche’s Ventana Medical Systems Inc. unit will develop companion diagnostics for compounds being developed by Astellas, including the pharma’s ASP5878. The fibroblast growth factor (FGF) receptor (...